Consumer Cost Sharing and Use of Biopharmaceuticals for Rheumatoid Arthritis
June 11th 2013Consumer cost sharing reduces use of physician-administered specialty drugs for patients suffering from rheumatoid arthritis, with an offsetting increase in patient self-administered specialty drugs.